Is this ever going to end?
The World Health Organisation has recommended that a malaria vaccine developed by GlaxoSmithKline should be widely used in children in Africa and other parts of the world. The drug, was created in 1987, and in October 2019 a paper in ‘Human Vaccines and Immunotherapeutics’ reported that the first generation vaccine demonstrated ‘modest efficacy against malaria illness’.
According to the Financial Times, the drug, called Mosquirix, is being used in experimental pilot studies and more than 800,000 children in Ghana, Kenya and Malawi have been given…
Disclaimer
Some of the posts we share are controversial and we do not necessarily agree with them in the whole extend. Sometimes we agree with the content or part of it but we do not agree with the narration or language. Nevertheless we find them somehow interesting, valuable and/or informative or we share them, because we strongly believe in freedom of speech, free press and journalism. We strongly encourage you to have a critical approach to all the content, do your own research and analysis to build your own opinion.
We would be glad to have your feedback.
Source: Dr Vernon Coleman - MB ChB DSc Read the original article here: https://vernoncoleman.org/